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Encapsulation of miRNA in chitosan nanoparticles as a candidate for an anti-metastatic 
agent in cancer therapy 
ABSTRACT 
MicroRNAs (miRNA) have been utilised as a repressor molecule for metastasis of tumours, 
as it inhibits fundamental processes related to cellular and physiological pathway of the 
tumour at the mRNA level. However, therapeutic application of miRNAs is impaired by 
premature degradation in the extracellular environment by endonucleases. This research 
describes the optimisation, chemical, and morphological characterisation of nanoparticles for 
effective encapsulation of miRNA-186 and evaluate its efficiency as anti-metastatic agent in 
non-small cell lung carcinoma monolayer. Through ionic gelation methods, the miRNA was 
encapsulated in chitosan nanoparticles (CNPs), a drug carrier with high particle stability, low 
cellular toxicity, and robust preparation methods. Physiochemical and morphological 
characterization analysis through light scattering analysis showed miRNA-CNP sizes below 
200 nm, with a low polydispersity index and exhibition of irregular spherical shape of the 
nanoparticles synthesised through FESEM analysis. Additionally, in vitro nanoparticle 
efficacy evaluated through scratch assay suggests a decrease in invasion ability of cancer 
cells exhibited by miRNA-CNP.  
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